Pharmaceutical Research and Consulting, Inc

Dallas, Texas 75231

We've found

3 trials

at this facility

A Dose Escalation Study of AF-219 in Refractory Chronic Cough

Status: Enrolling, Phase II
Updated: 11/19/2015

from

Dallas, TX

A Dose Escalation Study of Bradanicline in Refractory Chronic Cough

Status: Enrolling, Phase II
Updated: 12/31/1969

from

Dallas, TX

Phase 3 Study of Gefapixant (MK-7264) in Adult Participants With Chronic Cough (MK-7264-027)

Status: Enrolling, Phase III
Updated: 12/31/1969

from

Dallas, TX

Use our guide to learn which trials are right for you!